Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects

Thrombosis Research

Volumn 110, Issue 1, 2003, Pages 39-46

  Anfossi, Giovanni ^a   Russo, Isabella ^a   Massucco, Paola ^a   Mattiello, Luigi ^a   Trovati, Mariella ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Amifostine; Glyceryl trinitrate; Insulin resistance; N acetyl L cysteine; Obesity; Platelets; Sodium nitroprusside; Superoxide dismutase

Indexed keywords

ACETYLCYSTEINE; AMIFOSTINE; ANTIOXIDANT; CYCLIC GMP; GLYCERYL TRINITRATE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; EXPERIMENTAL TEST; EXPOSURE; FEMALE; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; MALE; OBESITY; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; VASCULAR RESISTANCE;

EID: 0038784498     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00284-6     Document Type: Article

References (39)

1. Meister A., Anderson M.E., Hwang O. Intracellular cysteine and glutathione delivery system. Am. J. Coll. Nutr. 5:1986;137-151.
2. Burgunder J.M., Varriale A., Lauterburg B.H. Effect of N-acetylcysteine on plasma cysteine and glutathione levels following paracetamol administration. Eur. J. Clin. Pharmacol. 36:1989;127-131.
3. Boesgaard S., Nielsen-Kudskend E., Laursen J.B., Aldershvile J. Thiols and nitrates: reevaluation of the thiol depletion theory of nitrate tolerance. Am. J. Cardiol. 81(1A):1998;21A-29A.
4. Stamler J.S., Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr. Rev. 54:1996;1-30.
5. Anfossi G., Russo I., Massucco P., Mattiello L., Cavalot F., Trovati M. N-acetyl-L-cysteine exerts direct antiaggregating effect on human platelets. Eur. J. Clin. Invest. 31:2001;452-461.
6. Anfossi G., Russo I., Massucco P., Mattiello L., Perna P., Tassone F.et al. L-arginine modulates aggregation and intracellular cyclic 3′,5′-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent. Thromb. Res. 94:1999;307-316.
7. Ignarro L.J., Lippton H., Edwards J.C., Baricos W.H., Hyman A.L., Kadowitz P.J.et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrite, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218:1981;739-749.
8. Loscalzo J. N-acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J. Clin. Invest. 76:1985;703-708.
9. Stamler J., Cunningham M., Loscalzo J. Reduced thiols and the effect of intravenous nitroglycerin on platelet aggregation. Am. J. Cardiol. 62:1988;377-380.
10. Radomski M.W., Palmer R.M.J., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. U. S. A. 87:1990;5193-5197.
11. Moro M.A., Russell R.J., Cellek S., Lizasoain I., Su Y., Darley-Usmar V.M.et al. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U. S. A. 93:1996;1480-1485.
12. Myers P.R., Minor R.L., Guerra R., Bates J.N., Harrison D.G. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocystein than nitric oxide. Nature. 345:1990;161-163.
13. Stamler J.S., Loscalzo J. The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders. J. Am. Coll. Cardiol. 18:1991;1529-1536.
14. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ. Res. 88:2001;756-762.
15. Trovati M., Mularoni E., Burzacca S., Ponziani M.C., Massucco P., Mattiello L.et al. Impaired insulin-induced platelet antiaggregating effect in obesity and in obese non-insulin-dependent diabetes mellitus. Diabetes. 44:1995;1318-1322.
16. Trovati M., Massucco P., Mattiello L., Piretto V., Cavalot F., Mularoni E.et al. The insulin-induced increase of guanosine-3′,5′-cyclic monophosphate in human platelets is mediated by nitric oxide. Diabetes. 43:1996;1015-1019.
17. Trovati M., Anfossi G., Massucco P., Mattiello L., Costamagna C., Piretto V.et al. Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3′,5′-cyclic monophosphate and adenosine-3′,5′-cyclic monophosphate. Diabetes. 46:1997;742-749.
18. Anfossi G., Mularoni E.M., Burzacca S., Ponziani M.C., Massucco P., Mattiello L.et al. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. Diabetes Care. 21:1998;121-126.
19. Karlberg K.-E., Torfgard K., Ahlner J., Sylven C. Dose-dependent effect of intravenous nitroglycerin on platelet aggregation, and correlation with plasma glyceryl dinitrate concentration in healthy men. Am. J. Cardiol. 69:1992;802-805.
20. Weber A.A., Neuhaus T., Seul C., Dusing R., Schror K., Sachinidis A.et al. Biotransformation of glyceryl trinitrate by blood platelets as compared to vascular smooth muscle. Eur. J. Pharmacol. 309:1996;209-213.
21. Watanabe H., Kakihara M., Ohtsudka S., Enomoto T., Yasui K., Sugishita Y. Platelet cyclic GMP: a potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance. Circulation. 88:1993;29-36.
22. Perticone F., Ceravolo R., Condigliota M., Ventura G., Iacopino S., Sinopoli F.et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress. Protective role of vitamin C. Diabetes. 50:2001;159-165.
23. Dandona P., Mohanty P., Ghanim H., Aljada A., Browne R., Hamouda W.et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J. Clin. Endocrinol. Metab. 86:2001;355-362.
24. Keaney J.F., Larson M.G., Vasan R.S., Wilson P.W.F., Lipinska I., Corey D.et al. Obesity and systemic oxidative stress. Clinical correlates of oxidative stress in the Framingham Study. Arterioscler. Thromb. Vasc. Biol. 23:2003;434-439.
25. MacKenzie A., Filippini S., Martin W. Effects of superoxide dismutase mimetics on the activity of nitric oxide in rat aorta. Br. J. Pharmacol. 127:1999;1159-1164.
26. Mugge A., Elwell J.K., Peterson T.A., Harrison D.G. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am. J. Physiol. Cell Physiol. 260:1991;C219-C225.
27. Marzatico F., Porta C., Moroni M., Bertorelli L., Borasio E., Finotti N.et al. In vitro antioxidant properties of amifostine (WR-2721, Ethyol™). Cancer Chemother. Pharmacol. 45:2000;172-176.
28. Porta C., Maiolo A., Tua A., Grignani G. Amifostine, a reactive oxygen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Haematologica. 85:2000;820-825.
29. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 28:1985;412-419.
30. Haffner S.M., Miettinen H., Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 20:1997;1087-1092.
31. Ferrannini E., Mari A. How to measure insulin sensitivity. J. Hypertens. 16:1998;895-906.
32. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927-929.
33. Weiss H.J., Rogers J. Thrombocytopenia due to abnormalities in platelet release reaction. Blood. 39:1972;2-8.
34. Capizzi R. Amifostine: the preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies. Semin. Oncol. 23(Suppl. 8):1996;2-17.
35. Meng Y.Y., Trachtenburg J., Ryan U.S., Abendschein D.R. Potentiation of endogenous nitric oxide with superoxide dismutase inhibits platelet-mediated thrombosis in injured and stenotic arterioles. J. Am. Coll. Cardiol. 25:1995;269-275.
36. Grundy S.M. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 105:2002;2696-2698.
37. McGill H.C., McMahan C.A., Herderick E.E., Zieske A.W., Malcom G.T., Tracy R.E.et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 105:2002;2712-2718.
38. Ross R. Atherosclerosis: an inflammatory disease. New Engl. J. Med. 340:1999;115-126.
39. Massberg S., Brand K., Gruner S., Page S., Muller E., Muller I.et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196:2002;887-896.